Vivos Institute
Brad Amman has extensive experience in finance and administration, with a focus on healthcare and technology companies. Brad has worked as CFO for Vivos Therapeutics, where they helped distribute medical devices for addressing obstructive sleep apnea. Prior to that, they were CFO/COO at InLight Medical, a company specializing in light therapy products. Brad also served as CFO at CereScan Corp., a provider of brain imaging and diagnostic tools. Earlier in their career, Brad held various financial roles at LifeVantage Corporation, SKYDEX Technologies, MediaOne Group, Jones International Inc, and Arthur Andersen & Co. Their accomplishments include developing financial and operational strategies for scalability and implementing effective reporting processes.
Brad Amman's education history begins in 1977 when they attended Littleton High School. After completing their high school education, they went on to attend the University of Denver from 1980 to 1984. During this time, they obtained a Bachelor of Science (BS) degree in Accounting. In 1984, Brad enrolled at the University of Notre Dame where they pursued a Master of Business Administration (MBA) degree. Brad completed their MBA studies in 1985 from both the University of Notre Dame and its Mendoza College of Business. Their MBA specialized in taxation.
This person is not in any teams
Vivos Institute
Vivos Therapeutics is dedicated to transforming and improving lives by collaborating with top healthcare professionals and through innovative treatment modalities, advanced clinical protocols and solutions that may improve the overall health and wellness of people around the world. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Combining technologies and protocols that alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can possibly eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. Sales of the Vivos System are driven by the Vivos Integrated Practice (VIP) program, which offers dentists training and value-added services in connection with their use of the Vivos System. For more information, visit www.vivoslife.com